ValuationViz

KYMR fund manager activity

Kymera Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q3 2024 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalNo change20,000$2,293,4000.00%Aug 14, 2026
Ken Fisher - Fisher Asset ManagementNew12,732$1,459,9780.00%Aug 4, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalNo change20,000$1,665,8000.01%May 15, 2026

Older quarters